Cargando…
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers
T cell antigen receptor (TCR) signaling drives distinct responses depending upon the differentiation state and context of CD8(+) T cells. We hypothesized that access of signal-dependent transcription factors (TFs) to enhancers is dynamically regulated to shape transcriptional responses to TCR signal...
Autores principales: | Roychoudhuri, Rahul, Clever, David, Li, Peng, Wakabayashi, Yoshiyuki, Quinn, Kylie M., Klebanoff, Christopher A., Ji, Yun, Sukumar, Madhusudhanan, Eil, Robert L., Yu, Zhiya, Spolski, Rosanne, Palmer, Douglas C., Pan, Jenny H., Patel, Shashank J., Macallan, Derek C, Fabozzi, Giulia, Shih, Han-Yu, Kanno, Yuka, Muto, Akihiko, Zhu, Jun, Gattinoni, Luca, O’Shea, John J., Okkenhaug, Klaus, Igarashi, Kazuhiko, Leonard, Warren J., Restifo, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918801/ https://www.ncbi.nlm.nih.gov/pubmed/27158840 http://dx.doi.org/10.1038/ni.3441 |
Ejemplares similares
-
Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015) -
Cish actively silences tcr signaling in CD8+ T cells to maintain tumor tolerance
por: Palmer, Douglas, et al.
Publicado: (2015) -
Modulating immunometabolism of tumor specific mouse and human lymphocytes to enhance T cell based therapy for cancer
por: Sukumar, Madhusudhanan, et al.
Publicado: (2015) -
BACH2 represses effector programmes to stabilize Treg-mediated immune homeostasis - a new target in tumor immunotherapy?
por: Roychoudhuri, Rahul, et al.
Publicado: (2013) -
Ionic immune suppression within the tumour microenvironment limits T cell effector function
por: Eil, Robert, et al.
Publicado: (2016)